title: Human telomerase RNA expression and MIB-1 (Ki-67) proliferation index distinguish hemangioblastomas from metastatic renal cell carcinomas.
abstract: Hemangioblastomas are low-grade, capillary rich neoplasms of the cerebellum and spinal cord that can occur sporadically or in the setting of Von Hippel-Lindau syndrome. The present study analyzed the utility of proliferation potential in differentiating hemangioblastoma from RCC metastatic to the central nervous system using a MIB-1 (Ki-67) labeling index and assessment of expression of the RNA component of telomerase. Immunohistochemical analysis for epithelial membrane antigen (EMA) and MIB-1 was performed on paraffin-embedded sections of 27 hemangioblastomas and 5 RCC metastatic to the central nervous system. All but one hemangioblastoma demonstrated low or negative MIB-1 immunoreactivity, while 4 of 5 RCC metastases had moderate or high labeling indices. Telomerase RNA expression was assessed in 10 hemangioblastomas and in all 5 metastatic RCC by in Situ hybridization. All 10 hemangioblastomas demonstrated a lack of expression of telomerase RNA, while all 5 metastatic RCCs showed moderate to strong expression. Our results suggest that the MIB-1 labeling index is useful in differentiating hemangioblastoma from metastatic RCC and assessment of telomerase expression can also provide novel information on the difference in growth potential of these tumors.
authors.affiliation: Department of Pathology, University of Texas Southwestern Medical School, Dallas 75235-9072, USA.
authors.forename: D F
authors.initials: DF
authors.lastname: Brown
authors.forename: A F
authors.initials: AF
authors.lastname: Gazdar
authors.forename: C L
authors.initials: CL
authors.lastname: White
authors.forename: K
authors.initials: K
authors.lastname: Yashima
authors.forename: J W
authors.initials: JW
authors.lastname: Shay
authors.forename: E J
authors.initials: EJ
authors.lastname: Rushing
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002292:Carcinoma, Renal Cell / Q000175:diagnosis / Q000378:metabolism* / Q000556:secondary; D016543:Central Nervous System Neoplasms / Q000175:diagnosis / Q000378:metabolism* / Q000556:secondary; D003937:Diagnosis, Differential; D005260:Female; D018325:Hemangioblastoma / Q000175:diagnosis / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D019394:Ki-67 Antigen / Q000378:metabolism*; D007680:Kidney Neoplasms / Q000175:diagnosis / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D018396:Mucin-1 / Q000378:metabolism; D012313:RNA / Q000378:metabolism*; D019098:Telomerase / Q000235:genetics*
chemical_list: D019394:Ki-67 Antigen; D018396:Mucin-1; D012313:RNA; D019098:Telomerase